Cancel anytime
Globe Life Inc (GL)GL
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: GL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 43.04% | Upturn Advisory Performance 5 | Avg. Invested days: 83 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 43.04% | Avg. Invested days: 83 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 5 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.18B USD |
Price to earnings Ratio 9.3 | 1Y Target Price 131.9 |
Dividends yield (FY) 0.87% | Basic EPS (TTM) 11.75 |
Volume (30-day avg) 590174 | Beta 0.81 |
52 Weeks Range 38.75 - 131.03 | Updated Date 11/19/2024 |
Company Size Mid-Cap Stock | Market Capitalization 9.18B USD | Price to earnings Ratio 9.3 | 1Y Target Price 131.9 |
Dividends yield (FY) 0.87% | Basic EPS (TTM) 11.75 | Volume (30-day avg) 590174 | Beta 0.81 |
52 Weeks Range 38.75 - 131.03 | Updated Date 11/19/2024 |
Earnings Date
Report Date 2024-10-23 | When AfterMarket |
Estimate 3.06 | Actual 3.49 |
Report Date 2024-10-23 | When AfterMarket | Estimate 3.06 | Actual 3.49 |
Profitability
Profit Margin 19.04% | Operating Margin (TTM) 28.29% |
Management Effectiveness
Return on Assets (TTM) 3.31% | Return on Equity (TTM) 23.55% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 9.3 | Forward PE 10.44 |
Enterprise Value 11803419396 | Price to Sales(TTM) 1.6 |
Enterprise Value to Revenue 2.06 | Enterprise Value to EBITDA - |
Shares Outstanding 83945104 | Shares Floating 81817896 |
Percent Insiders 2.42 | Percent Institutions 84.3 |
Trailing PE 9.3 | Forward PE 10.44 | Enterprise Value 11803419396 | Price to Sales(TTM) 1.6 |
Enterprise Value to Revenue 2.06 | Enterprise Value to EBITDA - | Shares Outstanding 83945104 | Shares Floating 81817896 |
Percent Insiders 2.42 | Percent Institutions 84.3 |
Analyst Ratings
Rating 3.9 | Target Price 126.56 | Buy 3 |
Strong Buy 3 | Hold 4 | Sell - |
Strong Sell - |
Rating 3.9 | Target Price 126.56 | Buy 3 | Strong Buy 3 |
Hold 4 | Sell - | Strong Sell - |
AI Summarization
Globe Life Inc. (NYSE: GL) - Comprehensive Overview
Company Profile
History and Background:
Founded in 1954 as Globe Life and Accident Insurance Company, Globe Life Inc. is a Fortune 1000 and S&P 500 company headquartered in McKinney, Texas. Originally established by insurance professionals R. Ralph Thomas and Gordon Palmer, the company initially offered burial insurance products and has since grown to encompass a range of life and supplemental health insurance products.
Core Business Areas:
- Life Insurance: Offers a suite of term, whole, and universal life insurance with flexible coverage options to individuals and families.
- Supplemental Health Insurance: Provides various products, including accident, critical illness, cancer, and hospital Indemnity insurance.
- Annuity Products: Offers fixed, indexed, and variable annuities to help individuals plan for retirement.
Leadership and Structure:
Globe Life Inc. is led by President and CEO Gary Coleman and a diverse executive team with extensive experience in the insurance industry. The company operates under a decentralized structure, with four primary segments: Individual Life, Accident & Health, Liberty National, and Direct Market.
Top Products and Market Share
Top Products:
- Term Life Insurance: Offers flexible term lengths, coverage amounts, and riders.
- Whole Life Insurance: Provides lifelong coverage with guaranteed death benefit and cash value accumulation.
- Universal Life Insurance: Combines permanent life insurance with flexible premium and death benefit options.
- Accident & Health Insurance: Offers protection against accidents, critical illnesses, cancer, and hospitalization costs.
Market Share:
- Globe Life holds an estimated 2% market share in the US individual life insurance market.
- Its market share in the supplemental health insurance segment is less defined due to the product's diverse nature, but it is a leading competitor in this space.
Comparison to Competitors:
Globe Life competes with major life insurers like MetLife, Prudential, and Lincoln Financial, as well as specialized supplemental health insurers like Aflac and Cigna. Globe Life differentiates itself by focusing on affordable, simplified products primarily sold through its own agency force, which offers personalized customer service.
Total Addressable Market (TAM)
The global life insurance market is estimated to be worth over $2.5 trillion, with the US market accounting for roughly 40% of the total. The supplemental health insurance market is also substantial, estimated to be valued at over $200 billion globally.
Financial Performance
Recent Performance:
Globe Life Inc. has demonstrated steady financial performance in recent years. In 2022, the company reported total revenue of $11.2 billion, net income of $532.2 million, and diluted EPS of $3.95.
Profitability and Margins:
The company boasts healthy profit margins, with a net profit margin of nearly 5% as of 2022. Its operating margin also remains stable at around 12%.
Cash Flow and Balance Sheet:
Globe Life Inc. maintains a strong cash position and healthy balance sheet with manageable debt levels.
Dividends and Shareholder Returns
Dividend History:
The company has a consistent dividend payment history, increasing its payout annually over the last decade. In 2022, Globe Life paid a dividend of $2.04 per share, yielding approximately 3%. The current payout ratio is around 50%, indicating room for future dividend growth.
Shareholder Returns:
Over the past 5 and 10 years, Globe Life Inc. has delivered total shareholder returns of over 100% and 250%, respectively, significantly outperforming the broader market.
Growth Trajectory
Historical Growth:
Globe Life Inc. has experienced consistent growth in recent years, with its net income and EPS increasing at a compound annual growth rate (CAGR) of 11% and 12%, respectively, over the past five years.
Future Growth Projections:
Analysts anticipate continued growth for Globe Life, with projected EPS CAGR of around 8% over the next five years. This growth is expected to be driven by increased sales and market penetration, along with continued product diversification.
Growth Strategies:
The company's growth plans include expanding distribution channels, introducing new products, and leveraging its digital capabilities to reach more customers.
Market Dynamics
Industry Trends:
The life insurance industry is undergoing a transformation driven by technological advancements, changing customer preferences, and increasing regulatory scrutiny. The trend is towards simplified and accessible products, offered through digital channels and tailored to specific customer needs.
Globe Life's Positioning:
The company is well-positioned to adapt to these trends with its focus on simplified products, direct marketing approach, and digital initiatives.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Globe Life Inc
Exchange | NYSE | Headquaters | McKinney, TX, United States |
IPO Launch date | 1987-12-30 | Co-Chairman & Co-CEO | Mr. Frank Martin Svoboda |
Sector | Financial Services | Website | https://www.home.globelifeinsurance.com |
Industry | Insurance - Life | Full time employees | 3636 |
Headquaters | McKinney, TX, United States | ||
Co-Chairman & Co-CEO | Mr. Frank Martin Svoboda | ||
Website | https://www.home.globelifeinsurance.com | ||
Website | https://www.home.globelifeinsurance.com | ||
Full time employees | 3636 |
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities. The company sells its products through its direct to consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.